Women's Health Care Nurse Practitioner Exam
Women's Health Care Nurse Practitioner Exam is a trademark of its owner, which is not affiliated with and does not endorse Test Treasure Publication or TTP Prep.
Women's Health Care Nurse Practitioner Exam is a trademark of its owner, which is not affiliated with and does not endorse Test Treasure Publication or TTP Prep.
10 sample questions for the Women's Health Care Nurse Practitioner Exam, with the correct answer and an explanation for each. No account needed. Try each one before you open the answer.
Sections covered on the exam: Pregnancy Physiology, Prenatal Care and Fetal Assessment, Breast Disorders and Gynecologic Cancers, Health History and Physical Examination, Pharmacology for Women's Health, Professional Practice Issues.
Question 1 · Pregnancy Physiology, Prenatal Care and Fetal Assessment
Answer: B. Diagnostic mammogram with targeted breast ultrasound
A persistent discrete breast mass in a woman 40 or older is evaluated first with diagnostic mammography plus targeted ultrasound, which together characterize the lesion and guide biopsy. Waiting for another cycle is reasonable only for vague, cyclic nodularity, not for a firm, irregular mass that has already persisted. MRI is not the initial study for a palpable mass and is reserved for selected problem-solving or high-risk screening.
Question 2 · Breast Disorders and Gynecologic Cancers
Answer: C. In 6 to 8 weeks
Levothyroxine has a half-life of about 7 days, so a new steady state and stable TSH take about 6 weeks; TSH is rechecked 6 to 8 weeks after each dose change. Testing at 1 to 2 weeks reflects an incomplete adjustment and can prompt unnecessary changes. Waiting 6 months delays correction; that interval is used once she is stable on her dose.
Question 3 · Health History and Physical Examination
Answer: C. Ceftriaxone IM plus doxycycline and metronidazole for 14 days
A sexually active young woman with pelvic pain and cervical motion, uterine or adnexal tenderness meets CDC minimum criteria for pelvic inflammatory disease and should be treated empirically now: ceftriaxone 500 mg IM once plus doxycycline 100 mg and metronidazole 500 mg twice daily for 14 days, with reassessment in 72 hours. Single-dose therapy is inadequate for an upper genital tract infection. Delaying treatment while tests are pending raises the risk of infertility, ectopic pregnancy and chronic pelvic pain.
Question 4 · Health History and Physical Examination
A 30-year-old G2P1 at 26 weeks' gestation completed a one-step 75 g, 2-hour oral glucose tolerance test after an overnight fast. The results are shown.
| Time | Plasma glucose |
|---|---|
| Fasting | 88 mg/dL (4.9 mmol/L) |
| 1 hour | 186 mg/dL (10.3 mmol/L) |
| 2 hours | 148 mg/dL (8.2 mmol/L) |
Answer: B. Gestational diabetes is diagnosed
With the one-step 75 g test, a single value at or above the thresholds (fasting 92, 1 hour 180, 2 hours 153 mg/dL) establishes gestational diabetes, and the 1-hour value of 186 mg/dL meets that criterion. Calling the test normal ignores the elevated 1-hour value. The 100 g 3-hour test is the second step of the two-step approach after an abnormal 50 g screen, not a confirmation of a one-step result.
Question 5 · Health History and Physical Examination
Answer: B. Daily vaginal progesterone
A singleton pregnancy with a cervical length of 20 mm or less before 24 weeks and no prior spontaneous preterm birth is treated with daily vaginal progesterone, which lowers the risk of preterm birth. Ultrasound-indicated cerclage is for patients with a prior spontaneous preterm birth and a cervix under 25 mm. Bed rest does not prevent preterm birth and raises the risk of thromboembolism and deconditioning.
Question 6 · Pregnancy Physiology, Prenatal Care and Fetal Assessment
Answer: A. Targeted breast ultrasound
In women younger than 30, ultrasound is the first imaging test for a palpable breast mass because dense breast tissue limits mammography and radiation is avoided; this mass is typical of a fibroadenoma. Mammography is added only if ultrasound is suspicious. MRI is not used as the initial test for a palpable mass.
Question 7 · Breast Disorders and Gynecologic Cancers
Answer: A. Stop semaglutide at least 2 months before trying to conceive
Weight-loss GLP-1 receptor agonists are not used in pregnancy, and because semaglutide has a long half-life, labeling advises stopping it at least 2 months before a planned pregnancy. Continuing until a positive test exposes the embryo during organogenesis. Continuing through the first trimester is not recommended, since weight loss is not a goal in pregnancy.
Question 8 · Health History and Physical Examination
Answer: C. Refer for biopsy of the Bartholin gland mass
Bartholin gland enlargement in a woman 40 or older, especially a firm or solid mass after menopause, requires biopsy or excision to exclude Bartholin gland carcinoma. Sitz baths are for small symptomatic cysts or early abscesses in younger women and would delay diagnosis here. Word catheter drainage treats a fluctuant cyst or abscess and does not provide tissue diagnosis of a solid mass.
Question 9 · Health History and Physical Examination
A 36-year-old G2P1 at 12 weeks' gestation chose cell-free DNA screening. The laboratory report is shown.
| Condition | Result |
|---|---|
| Trisomy 21 | High risk detected |
| Trisomy 18 | Low risk |
| Trisomy 13 | Low risk |
| Fetal fraction | 9% |
Answer: B. Offer CVS now or amniocentesis at 15 weeks or later
Cell-free DNA is the most sensitive aneuploidy screen, but it is still a screen with false positives (often from placental mosaicism), so a high-risk result needs diagnostic testing, by chorionic villus sampling at 10 to 13 weeks or amniocentesis from 15 weeks, before any irreversible decision. Treating the screen as a diagnosis risks acting on a false-positive result. Repeating the same screen does not confirm the fetal karyotype.
Question 10 · Health History and Physical Examination
Answer: C. Gestational transient thyrotoxicosis
High hCG in early pregnancy stimulates the TSH receptor, causing transient suppression of TSH and mild free T4 elevation, especially with hyperemesis; it resolves by the mid second trimester and is managed with supportive care, not antithyroid drugs. Graves disease is suggested by goiter, ophthalmopathy and positive receptor antibodies, none of which she has. A toxic adenoma would usually present with a palpable thyroid nodule and is not driven by hCG.
TTP Prep has 200 Women's Health NP practice questions with explanations, timed and mock-exam modes, 500 flashcards, interactive lessons, a printable cheat sheet and a readiness score. Start free, no card needed.
More free questions: browse every exam.